|
Jun 27
|
These Stocks Are Moving the Most Today: Lordstown, Unity, Walgreens, Generac, Carnival, and More
|
|
Jun 27
|
Why Lilly's Obesity Treatment Update Sent Novo, Madrigal And Viking Shares Diving
|
|
Jun 27
|
These Stocks Are Moving the Most Today: Lordstown, Unity, Walgreens, Generac, and More
|
|
Jun 27
|
Eli Lilly Shares Rise After Drug Helps Patients Lose More Weight Than Competitors
|
|
Jun 27
|
NVS or LLY: Which Is the Better Value Stock Right Now?
|
|
Jun 27
|
Why Eli Lilly Stock Briefly Popped Today
|
|
Jun 27
|
Walgreens cuts guidance, Meta price target boost, Eli Lilly's obesity drug: trending tickers
|
|
Jun 27
|
Pfizer (PFE) Stock Down on Halting Development of Obesity Drug
|
|
Jun 27
|
Calculating The Intrinsic Value Of Eli Lilly and Company (NYSE:LLY)
|
|
Jun 27
|
5 Things to Know Before Markets Open
|
|
Jun 27
|
Fed Will Pay High Price to Bring Down Inflation. Investors Should Take Note.
|
|
Jun 27
|
Stocks Nudge Higher, Nvidia AI Deal, Walgreens Boots Earnings, Eli Lilly Obesity Drug, Lordstown Bankruptcy - 5 Things To Know
|
|
Jun 27
|
More evidence needed on Lilly's weight loss drug, UK watchdog says
|
|
Jun 27
|
Mergers Are Down, but These 2 Sectors Are Booming
|
|
Jun 27
|
The Drugs That Are Gaining On Ozempic
|
|
Jun 26
|
Lilly experimental 'triple G' obesity drug leads to 24.2% weight loss in trial
|
|
Jun 26
|
Lilly's phase 2 retatrutide results published in The New England Journal of Medicine show the investigational molecule achieved up to 17.5% mean weight reduction at 24 weeks in adults with obesity and overweight
|
|
Jun 26
|
Pfizer Stock Tumbles On 'A Big Setback' In Obesity Treatment Vs. Novo Nordisk, Eli Lilly
|
|
Apr 27
|
Eli Lilly Highlights Weight Loss Data For Tirzepatide In Diabetes Patients
|
|
Apr 27
|
Ozempic Rival Mounjaro Helps Diabetes Patients Lose ‘Meaningful’ Weight, Study Shows
|